MINNEAPOLIS, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cleanroom operators will now be able to detect the presence of extremely low levels of microbial cells on surfaces much faster than traditional solutions. The capability is a result of a global marketing agreement between MOCON, Inc. (NASDAQ:MOCO) and Particle Measuring Systems.
MOCON’s GreenLight® system has a proven track record in reliability, sensitivity and speed across applications in many industries. It requires a fraction of the time needed by traditional plate counting methods to achieve results. The agreement gives Particle Measuring Systems exclusive rights to market GreenLight® technology to pharmaceutical companies worldwide.
To improve cleanroom testing, Particle Measuring Systems has developed the SurCapt™ Microbial Surface Detection Kit, using GreenLight® technology. This provides an all-inclusive, ready-to-use solution which simplifies and accelerates environmental surface testing for biological contamination. The design of the SurCapt kit reduces the likelihood of sample cross contamination and mishandling by the operator.
“By leveraging GreenLight® technology with our SurCapt™ Microbial Detection Kit, we are providing pharmaceutical companies the objective evidence they are currently missing in a timeframe that enables more effective decision-making. This breakthrough enhances quality assurance throughout the value chain,” said Giovanni Scialo, vice president, life sciences, Particle Measuring Systems.
About Particle Measuring Systems
Particle Measuring Systems, a Spectris company, provides life science and electronic companies with the contamination monitoring solutions needed for sterility assurance and yield loss protection. For more information visit www.pmeasuring.com
MOCON is a leading provider of detectors, instruments, systems and consulting services to research laboratories, production facilities, and quality control and safety departments in the medical, pharmaceutical, food and beverage, packaging, environmental, oil and gas and other industries worldwide. See www.mocon.com for more information.
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements that can be identified by words such as “will,” “may,” “expect,” “believe,” “anticipate,” “estimate,” “continue,” “planned,” or other similar expressions. All forward-looking statements speak only as of the date of this press release. MOCON undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. In addition to the risks and uncertainties of ordinary business operations and conditions in the general economy and the markets in which the Company competes, there are important factors that could cause actual results to differ materially from those anticipated by the forward-looking statements made in this press release. These factors include, but are not limited to, the performance of Dansensor, worldwide economic conditions and fluctuations in foreign currency exchange rates, the terms of our credit agreement including financial covenants included therein, dependence on certain key industries, pricing and lack of availability of raw materials, crude oil pricing impact on oil exploration activities, and other factors set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and other documents MOCON files with or furnishes to the Securities and Exchange Commission.
MOCON's shares are traded on the NASDAQ Global Market System under the symbol MOCO.
MOCON is a registered trademark of MOCON, Inc.; other trademarks are those of their respective holders.